Transcatheter Cardiovascular Therapeutics (TCT)

The Transcatheter Cardiovascular Therapeutics (TCT) conference is the Cardiovascular Research Foundation's (CRF) annual scientific symposium and the largest conference focused on interventional cardiovascular medicine. TCT includes seminars on all areas of intervention cardiology, structural heart, vascular in interventions, peripheral artery disease, and other procedures in the cath lab.

idea light bulb innovation

What to expect at the TCT MedTech Innovation Forum during TCT 2022

The all-day summit, a collaboration between CRF and Fogarty Innovation, will focus on advances in healthcare technologies and patient care.

Balloon expansion deployment of an Edwards Lifesciences Sapien 3 transcatheter aortic valve replacement (TAVR) device.

VIDEO: TAVR for asymptomatic patients with severe calcific aortic stenosis

Philippe Genereux, MD, medical director of the Structural Heart Disease Program at Morristown Medical Center, discusses the use of transcatheter aortic valve replacement (TAVR) procedures in patients with severe, calcific aortic stenosis who are asymptomatic. 

Three systems for left ventricular pacing during TAVR, modified TAVR valve delivery wire, the Opsens Savvy wire, and the Teleflex Wattson wire.

VIDEO: Use of temporary left ventricular pacing during TAVR procedures

Philippe Genereux, MD, medical director of the structural heart disease program at Morristown Medical Center, discusses the various options used for temporary pacing of the heart during transcatheter aortic valve replacement (TAVR) procedures.

Thumbnail

American Heart Association and Cardiovascular Research Foundation announce a new annual meeting collaboration

“Harnessing the strengths of our two pioneering organizations with extensive experience in translating the latest scientific breakthroughs into practical therapies is crucial," says AHA CEO Nancy Brown.

Thumbnail

Cardiac surgeons gaining procedural volume despite TAVR making up 84% of cases

A decade ago, when TAVR was first cleared by the FDA, surgeons had concern about losing business. But unexpectedly, TAVR has helped also gain heart surgery cases. 

A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare

VIDEO: How to build a collaborative heart team in structural heart

Brijeshwar Maini, MD, structural heart cardiologist, national and Florida medical director of cardiology, Tenant Health, explains what hospitals need to build a structural heart program and develop a heart-team care collaboration approach.

Anita Asgar, MD, MSc, FSCAI, director, transcatheter valve therapy research at Montréal Heart Institute, discusses a textbook she co-edited with Jason Rogers, MD, on the transcatheter edge-to-edge repair (TEER) of the mitral valve.

VIDEO: SCAI publishes free how-to textbook on TEER procedures

Anita Asgar, MD, discusses a free textbook available online she co-edited on the transcatheter edge-to-edge repair (TEER) of the mitral valve. 

Brijeshwar Maini, MD, FACC, structural heart cardiologist, national and Florida medical director of cardiology, explains his decision to leave clinical practice in the near future to become a full-time cardiac device manufacture business owner. It is a path several prominent cardiologists have made.

VIDEO: How this cardiologist became a full-time inventor and entrepreneur

Brijeshwar Maini, MD, explains his decision to leave clinical practice to become a full-time cardiac device business owner. It is a path several prominent cardiologists have made.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.